ATAXIA TELANGIECTASIA-MUTATED (ATM) SIGNALING PATHWAY (PW:0001361)
Description
DNA lesions, particularly double-strand breaks (DSBs), can have severe genotoxic effects if not promptly handled. DSBs can be initiated by DNA damaging agents such as ionizing radiation or arise during replication through exposure to metabolites, and are also physiological intermediates generated during V(D)J [variable (V), diversity (D) and joining (J) recombination] and class switch recombination in lymphocytes of the immune system. The cells possess a robust response mechanism to DNA damage which triggers a range of signals to adequately handle the damage and maintain genomic integrity, collectively known as the DNA damage response (DDR). Central to mediating the response are the DDR kinases - ataxia telangiectasia-mutated (ATM), ATM and RAD3-related (ATR) and DNA-dependent protein kinase (DNA-PKcs). Of these, ATM plays a pivotal role - its signaling is activated by DSBs to promote double-strand repair and prompt cell cycle checkpoint pathways, regulate cell fate decision (apoptosis or senescence), transcription and metabolic pathways. ATM, like the other DDR kinases, belongs to the phosphatidylinositol (PI) 3-kinase-like kinase (PIKK) family. It is a large serine/threonine kinase with an impressive repertoire of substrates, the size of which underlies the range of responses it can promote. As the name suggests, the human gene is mutated in the autosomal recessive condition associated with neurodegenerative and immunodeficiency phenotypes. A major function of ATM signaling is to activate the double-strand repair pathways. There are two principal DSB pathways: non-homologous end-joining (NHEJ) and homologous recombination (HR). The error-prone NHEJ which can be active throughout the cell cycle is the predominant one whereas the error-free HR is restricted to the S and G2 phases when sister chromatids are available to provide the necessary template. ATM signaling proceeds through several and overlapping layers, accompanied by activating positive feedback and regulatory negative inhibition loops. Two downstream sensors - Tp53bp1 and Brca1, prompt the unfolding of NHEJ or HR, respectively. ATM activation in response to DSBs involves autophosphorylation followed by monomerization and kinase activity and acetylation of a C-terminal lysine by Kat5, known as Tip60. The exact mechanism of ATM activation is still elusive; however, the presence of the MRN complex at the site of the DSB appears to be a requirement. The MRN complex is composed of Mre11a, Rad50 and Nbs1 proteins, of which the first two are important for DSB recognition and the latter for ATM recruitment; MRN itself is an ATM substrate. ATM phosphorylation of a histone variant - H2afx, at a conserved serine residue prompts its recognition by the mediator of DNA damage checkpoint protein 1 (Mdc1); Mdc1 also interacts with ATM for which it is a substrate. Mdc1 promotes a positive feedback resulting in additional accumulation of MRN-ATM and H2afx phosphorylation. Phosphorylated Mdc1 also recruits E3 ubiquitin ligase Rnf8 that in turn will lead to recruitment of Rnf168 E3 ligase for which H2afx is a substrate. E3, together with E2 ligases such as Ube2n, promote K63-linked polyubiquitination at DSBs leading to the generation of a chromatin domain, permissive for the recruitment of several proteins, including Tp53bp1 and Brca1. Additional E3 ligases such as the Rnf20-Rnf40 heterodimer, also an ATM substrate, are recruited in an H2afx independent manner. Tp53bp1 opposes the resection reaction that is central to the HR repair type, thus promoting NHEJ repair while Brca1 antagonizes Tp53bp1 to achieve the opposite effect, thus promoting the HR repair. The mechanisms by which the two proteins oppose each other to initiate the specific downstream repair route are incompletely understood. Tp53bp1 acts as a scaffold for additional interactors such as Rif1 and the chromatin modulator Mum1 (Expand1). On the other hand Brca1, which interacts with Rbbp8 (Ctip), may promote the eviction of Tp53bp1 and Rif1 to favor HR. Chromatin remodeling complexes are also recruited (not shown) and the identity of the complex may also impact on the choice of repair pathway. Tb53bp1 chromatin binding is dependent upon its homo-oligomerization and the dual recognition of histone 4 dimethylated at lysine 20 and of histone 2A ubiquitinated at lysine 15 (not shown). The ATM signaling network is highly regulated to avoid spreading of chromatin modification to undamaged sites, to disassemble/deactivate the components and to reinstate the cell cycle by stopping the checkpoint activation, among others. For instance, the balance between the constitutive phosphorylation of H2afx at tyrosine 142 by Baz1b and its dephosphorylation, dictates whether the response will lead to repair and survival or death via apoptosis. H2afx phosphorylated at both Y142 and Ser139 promotes apoptosis and possibly, local chromatin remodeling; dephosphorylation of Y142 promotes binding of Mdc1 and repair. A number of phosphatases, ubiquitin and SUMO ligases, and deubiquitinases regulate ATM, H2afx, Mdc1 and the K63 ubiquitination states.
To check the ontology report for annotations, GViewer and download, click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Atm
ATM serine/threonine kinase
ISO
RGD
PMID:23532176 PMID:21533982
RGD:8661225 , RGD:8661232
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511
G
Brca1
BRCA1, DNA repair associated
ISO
RGD
PMID:24326623
RGD:8661237
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
G
Brcc3
BRCA1/BRCA2-containing complex subunit 3
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185
G
Eya1
EYA transcriptional coactivator and phosphatase 1
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 5:9,646,599...9,884,609
Ensembl chr 5:9,646,591...9,884,614
G
Eya3
EYA transcriptional coactivator and phosphatase 3
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 5:150,090,535...150,218,855
Ensembl chr 5:150,137,256...150,218,852
G
H2ax
H2A.X variant histone
ISO
RGD
PMID:21533982 PMID:24002223
RGD:8661232 , RGD:8661242
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
Kat5
lysine acetyltransferase 5
ISO
RGD
PMID:23532176 PMID:21533982
RGD:8661225 , RGD:8661232
NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:212,325,090...212,332,587
G
Kdm4a
lysine demethylase 4A
ISO
RGD
PMID:24326623 PMID:24002223
RGD:8661237 , RGD:8661242
NCBI chr 5:136,958,178...137,004,942
Ensembl chr 5:136,958,178...137,004,951
G
L3mbtl1
L3MBTL histone methyl-lysine binding protein 1
ISO
RGD
PMID:24326623 PMID:24002223
RGD:8661237 , RGD:8661242
NCBI chr 3:172,014,774...172,053,181
Ensembl chr 3:172,021,416...172,053,181
G
Mdc1
mediator of DNA damage checkpoint 1
ISO
RGD
PMID:21533982 PMID:24002223
RGD:8661232 , RGD:8661242
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960
G
Mre11
MRE11 double strand break repair nuclease
ISO
RGD
PMID:21533982
RGD:8661232
NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:19,913,772...19,961,904
G
Nbn
nibrin
ISO
RGD
PMID:21533982
RGD:8661232
NCBI chr 5:34,256,678...34,291,163
Ensembl chr 5:34,256,627...34,291,162
G
Otub1
OTU deubiquitinase, ubiquitin aldehyde binding 1
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 1:213,816,400...213,824,679
Ensembl chr 1:213,816,400...213,824,679
G
Pias1
protein inhibitor of activated STAT, 1
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:72,233,566...72,334,315
G
Pias4
protein inhibitor of activated STAT, 4
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 7:9,197,032...9,210,557
Ensembl chr 7:9,196,896...9,210,527
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
ISO
RGD
PMID:21533982 PMID:24002223
RGD:8661232 , RGD:8661242
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
ISO
RGD
PMID:21533982 PMID:24002223
RGD:8661232 , RGD:8661242
NCBI chr10:36,856,534...36,878,789
G
Ppp4c
protein phosphatase 4, catalytic subunit
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168
G
Ppp5c
protein phosphatase 5, catalytic subunit
ISO
RGD
PMID:21533982
RGD:8661232
NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:86,818,297...86,842,950
G
Ppp6c
protein phosphatase 6, catalytic subunit
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 3:43,339,521...43,371,807
Ensembl chr 3:43,341,108...43,371,807
G
Psmd14
proteasome 26S subunit, non-ATPase 14
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:66,662,900...66,755,665
G
Pwwp3a
PWWP domain containing 3A, DNA repair factor
ISO
RGD
PMID:24326623
RGD:8661237
NCBI chr 7:10,115,865...10,132,696
Ensembl chr 7:10,115,866...10,130,925
G
Rad50
RAD50 double strand break repair protein
ISO
RGD
PMID:21533982
RGD:8661232
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
G
Rbbp8
RB binding protein 8, endonuclease
ISO
RGD
PMID:24326623
RGD:8661237
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:3,197,310...3,263,985
G
Rif1
replication timing regulatory factor 1
ISO
RGD
PMID:24326623
RGD:8661237
NCBI chr 3:56,963,840...57,017,106
Ensembl chr 3:56,963,854...57,017,106
G
Rnf168
ring finger protein 168
ISO
RGD
PMID:21533982 PMID:24326623
RGD:8661232 , RGD:8661237
NCBI chr11:81,991,352...82,013,306
Ensembl chr11:81,991,360...82,013,306
G
Rnf20
ring finger protein 20
ISO
RGD
PMID:23532176
RGD:8661225
NCBI chr 5:68,771,507...68,797,240
Ensembl chr 5:68,771,535...68,797,240
G
Rnf4
ring finger protein 4
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr14:80,625,864...80,647,138
Ensembl chr14:80,625,866...80,647,148
G
Rnf40
ring finger protein 40
ISO
RGD
PMID:23532176
RGD:8661225
NCBI chr 1:191,632,988...191,649,231
Ensembl chr 1:191,633,034...191,648,421
G
Rnf8
ring finger protein 8
ISO
RGD
PMID:21533982 PMID:24326623
RGD:8661232 , RGD:8661237
NCBI chr20:7,683,890...7,708,437
G
Tp53bp1
tumor protein p53 binding protein 1
ISO
RGD
PMID:24326623
RGD:8661237
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
G
Trip12
thyroid hormone receptor interactor 12
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 9:93,364,791...93,491,015
Ensembl chr 9:93,364,791...93,490,159
G
Ube2n
ubiquitin-conjugating enzyme E2N
ISO
RGD
PMID:21533982 PMID:24326623
RGD:8661232 , RGD:8661237
NCBI chr 7:32,041,190...32,071,252
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:71,000,197...71,109,813
G
Usp16
ubiquitin specific peptidase 16
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr11:40,166,651...40,196,792
Ensembl chr11:40,167,692...40,196,823
G
Usp3
ubiquitin specific peptidase 3
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:75,974,615...76,049,153
G
Usp44
ubiquitin specific peptidase 44
ISO
RGD
PMID:24002223
RGD:8661242
NCBI chr 7:30,251,142...30,301,185
Ensembl chr 7:30,251,205...30,297,906
G
Vcp
valosin-containing protein
ISO
RGD
PMID:24326623 PMID:24002223
RGD:8661237 , RGD:8661242
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387
Pathway Gene Annotations
Disease Annotations Associated with Genes in the ataxia telangiectasia-mutated (ATM) signaling pathway
Atm Acute Liver Failure , adenoid cystic carcinoma , Alzheimer's disease , Arenaviridae infectious disease , arteriosclerosis , ataxia telangiectasia , B-Cell Chronic Lymphocytic Leukemia , bilateral breast cancer , bile duct cancer , brain cancer , Brain Neoplasms , breast cancer , Breast Cancer, Familial , breast carcinoma , Breast Neoplasms , cancer , cataract , cerebellar ataxia , colon cancer , colon carcinoma , colorectal cancer , Colorectal Cancer 10 , congenital merosin-deficient muscular dystrophy 1A , dilated cardiomyopathy , disease of cellular proliferation , endometrial cancer , endometrial carcinoma , endometrial serous adenocarcinoma , esophagus squamous cell carcinoma , Experimental Colitis , Familial Pancreatic Carcinoma , Familial Prostate Cancer , female breast cancer , Fibrosis , Gastro-Enteropancreatic Neuroendocrine Tumor , Helicobacter Infections , hepatoblastoma , hepatocellular carcinoma , hereditary breast ovarian cancer syndrome , Hereditary Neoplastic Syndromes , herpes simplex virus keratitis , Herpesviridae Infections , human immunodeficiency virus infectious disease , Hypercholesterolemia , infertility , influenza A , Insulin Resistance , Kidney Reperfusion Injury , left ventricular failure , leukemia , liver cancer , liver cirrhosis , lung cancer , lung non-small cell carcinoma , lung small cell carcinoma , lung squamous cell carcinoma , lymphoma , Lynch syndrome 1 , mantle cell lymphoma , melanoma , Metabolic Syndrome , microcephaly , multiple myeloma , myocardial infarction , nasopharynx carcinoma , oral mucosa leukoplakia , oral squamous cell carcinoma , osteoporosis , Otorhinolaryngologic Neoplasms , ovarian cancer , ovarian carcinoma , Ovarian Neoplasms , pancreatic cancer , papillary thyroid carcinoma , Parkinson's disease , peripheral T-cell lymphoma , Pneumococcal Meningitis , polycythemia vera , pre-malignant neoplasm , Prenatal Exposure Delayed Effects , primary cutaneous T-cell non-Hodgkin lymphoma , prostate cancer , prostate carcinoma in situ , Prostatic Neoplasms , Radiation Pneumonitis , Retroviridae Infections , Rhabdoviridae Infections , senile cataract , Sepsis , Spinal Cord Injuries , squamous cell carcinoma , status epilepticus , stomach cancer , Stomach Neoplasms , Streptococcus pneumonia , T-cell prolymphocytic leukemia , urinary bladder cancer , X-linked cardiac valvular dysplasia Baz1b Williams-Beuren syndrome Brca1 adenoid cystic carcinoma , Animal Mammary Neoplasms , bilateral breast cancer , breast adenocarcinoma , breast cancer , Breast Cancer, Familial , breast carcinoma , breast ductal carcinoma , Breast Neoplasms , Burkitt lymphoma , carcinoma , cervical cancer , cervix uteri carcinoma in situ , Chromosome Breakage , colon cancer , colon carcinoma , colorectal cancer , colorectal carcinoma , disease of cellular proliferation , ductal carcinoma in situ , dysgerminoma , endometrial carcinoma , esophagus squamous cell carcinoma , Experimental Mammary Neoplasms , Familial Pancreatic Carcinoma , Familial Prostate Cancer , Fanconi anemia complementation group A , Fanconi anemia complementation group S , hereditary breast ovarian cancer syndrome , hereditary mixed polyposis syndrome 1 , Hereditary Neoplastic Syndromes , hereditary spastic paraplegia 11 , Hyperplasia , hypertension , infant-type hemispheric glioma , invasive ductal carcinoma , lung cancer , lung non-small cell carcinoma , mouth disease , nasopharynx carcinoma , Neoplastic Cell Transformation , ovarian cancer , ovarian carcinoma , Ovarian Neoplasms , ovary serous adenocarcinoma , pancreatic cancer , pancreatic carcinoma , peritoneum cancer , periventricular nodular heterotopia , Premature Aging , prostate cancer , Prostatic Neoplasms , punctate palmoplantar keratoderma type II , rhabdomyosarcoma , stomach cancer , stomach carcinoma , Triple Negative Breast Neoplasms , urinary bladder cancer , Urinary Bladder Neoplasm , uterine corpus cancer Brcc3 Hereditary Neoplastic Syndromes , Occupational Diseases , Pregnancy in Diabetics Eya1 anterior segment dysgenesis , branchiooculofacial syndrome , branchiootic syndrome , branchiootic syndrome 1 , branchiootorenal syndrome , branchiootorenal syndrome 1 , Cardiovascular Abnormalities , cataract , Cayler Cardiofacial Syndrome , Conductive Hearing Loss , Congenital Abnormalities , congenital heart disease , Craniofacial Abnormalities , focal segmental glomerulosclerosis , focal segmental glomerulosclerosis 1 , genetic disease , Hearing Loss , Lung Agenesis , mitochondrial myopathy , Otofaciocervical Syndrome 1 , prostate cancer , renal agenesis , renal hypoplasia H2ax Breast Neoplasms , Chemical and Drug Induced Liver Injury , Chromosome Breakage , Experimental Mammary Neoplasms , glioblastoma , hypertension , Kidney Reperfusion Injury , liver benign neoplasm , Liver Reperfusion Injury , Micronuclei, Chromosome-Defective , Myocardial Reperfusion Injury , Neoplasm Recurrence, Local , oral mucosa leukoplakia , oral squamous cell carcinoma , Polyploidy , status epilepticus , transient cerebral ischemia Kat5 B-cell lymphoma , breast cancer , iron deficiency anemia , malignant mesothelioma , NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES , Prostatic Neoplasms Kdm4a alopecia areata , breast cancer , Cardiomegaly , lung cancer , melanoma , prostate cancer , stomach carcinoma , urinary bladder cancer L3mbtl1 breast cancer , genetic disease Mdc1 breast carcinoma , cervical cancer , lung carcinoma , stomach carcinoma Mre11 Alzheimer's disease , Animal Disease Models , Ataxia Telangiectasia Like Disorder , ataxia-telangiectasia-like disorder 1 , breast carcinoma , colon cancer , Colonic Neoplasms , dementia , depressive disorder , dystonia , eccrine porocarcinoma , endometrial cancer , hereditary breast ovarian cancer syndrome , Hereditary Neoplastic Syndromes , lung adenocarcinoma , Lynch syndrome , malignant astrocytoma , Neurocutaneous Syndromes , ovarian cancer , Ovarian Neoplasms , Parkinsonism , primary ovarian insufficiency , Prostatic Neoplasms , rectum cancer , stomach carcinoma , Triple Negative Breast Neoplasms , urinary bladder cancer Nbn acute lymphoblastic leukemia , adenosine deaminase deficiency , Alzheimer's disease , aplastic anemia , breast cancer , Breast Cancer, Familial , breast carcinoma , colon carcinoma , COVID-19 , diffuse large B-cell lymphoma , disease of metabolism , Familial Prostate Cancer , hepatocellular carcinoma , hereditary breast ovarian cancer syndrome , Hereditary Neoplastic Syndromes , high grade glioma , lissencephaly , microcephaly , Neoplasm Recurrence, Local , Nijmegen breakage syndrome , ovarian cancer , ovarian carcinoma , pancreatic carcinoma , primary ovarian insufficiency , prostate cancer , Prostatic Neoplasms , rectum cancer , stomach cancer , stomatitis , T-cell acute lymphoblastic leukemia Otub1 IgA glomerulonephritis , lupus nephritis Pias1 Arsenic Poisoning , Brain Injuries , focal segmental glomerulosclerosis , nephronophthisis , skin disease Ppm1d Brain Stem Neoplasms , breast cancer , Breast Cancer, Familial , Breast Neoplasms , Desbuquois dysplasia , genetic disease , Hereditary Neoplastic Syndromes , high grade glioma , INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD , lung carcinoma , Neurodevelopmental Disorders , ovarian cancer , pre-malignant neoplasm Ppp2ca asthma , congestive heart failure , Experimental Liver Neoplasms , genetic disease , heart disease , Hyperalgesia , Myocardial Ischemia , Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities , Parkinson's disease , prostate cancer , type 2 diabetes mellitus Ppp4c coronary artery disease , oligoasthenoteratozoospermia , spondylocostal dysostosis 5 Ppp5c Left Ventricular Hypertrophy Ppp6c basal cell carcinoma , melanoma Psmd14 alcohol-associated liver disease , autistic disorder , Disease Progression , neuroblastoma Rad50 asthma , breast cancer , Breast Cancer, Familial , breast carcinoma , Breast Neoplasms , hepatocellular carcinoma , hereditary breast ovarian cancer syndrome , Hereditary Neoplastic Syndromes , invasive ductal carcinoma , liver cirrhosis , lung sarcomatoid carcinoma , myocardial infarction , myoepithelioma , Nijmegen Breakage Syndrome-Like Disorder , ovarian cancer , premature menopause , primary ovarian insufficiency , prostate cancer , transitional cell carcinoma Rbbp8 COVID-19 , Desbuquois dysplasia , genetic disease , microcephaly , Microcephaly with Mental Retardation and Digital Anomalies , multiple myeloma , pancreatic carcinoma , Seckel syndrome , Seckel syndrome 2 Rif1 nemaline myopathy 2 Rnf168 Disease Progression , genetic disease , lung non-small cell carcinoma , Riddle syndrome , squamous cell carcinoma Rnf20 acute biphenotypic leukemia , Arsenic Poisoning , breast cancer Rnf4 Angelman syndrome , Testicular Neoplasms Rnf40 nephrogenic diabetes insipidus Rnf8 autistic disorder Tp53bp1 Breast Neoplasms , Colonic Neoplasms , glioblastoma , lung non-small cell carcinoma , Lymphatic Metastasis , Ovarian Neoplasms , pancreatic cancer , pulmonary hypertension Trip12 Clark-Baraitser syndrome , Developmental Disease , genetic disease , intellectual disability , Neurodevelopmental Disorders , prostate cancer Ube2n Embryo Loss Ubr5 breast cancer , colon adenocarcinoma , colon cancer , gallbladder carcinoma , gastric adenocarcinoma , hepatocellular carcinoma , invasive ductal carcinoma , laryngeal carcinoma , long QT syndrome , lung adenocarcinoma , lung non-small cell carcinoma , Neurodevelopmental Disorders , stomach cancer Usp3 atrial fibrillation , lymphopenia , neutropenia Vcp Alzheimer's disease , amyotrophic lateral sclerosis , amyotrophic lateral sclerosis type 1 , amyotrophic lateral sclerosis type 6 , Animal Disease Models , Charcot-Marie-Tooth disease type 2Y , congenital myopathy 6 , Cytomegalovirus Infections , dementia , Developmental Disabilities , Disease Progression , frontotemporal dementia , frontotemporal dementia and/or amyotrophic lateral sclerosis 6 , genetic disease , inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1 , inclusion body myopathy with Paget disease of bone and frontotemporal dementia , inclusion body myositis , intellectual disability , Lewy body dementia , Muscle Weakness , Paget's disease of bone , paraplegia , Prostatic Neoplasms , Stevens-Johnson syndrome
acute biphenotypic leukemia Rnf20 Acute Liver Failure Atm acute lymphoblastic leukemia Nbn adenoid cystic carcinoma Atm , Brca1 adenosine deaminase deficiency Nbn alcohol-associated liver disease Psmd14 alopecia areata Kdm4a Alzheimer's disease Atm , Mre11 , Nbn , Vcp amyotrophic lateral sclerosis Vcp amyotrophic lateral sclerosis type 1 Vcp amyotrophic lateral sclerosis type 6 Vcp Angelman syndrome Rnf4 Animal Disease Models Mre11 , Vcp Animal Mammary Neoplasms Brca1 anterior segment dysgenesis Eya1 aplastic anemia Nbn Arenaviridae infectious disease Atm Arsenic Poisoning Pias1 , Rnf20 arteriosclerosis Atm asthma Ppp2ca , Rad50 ataxia telangiectasia Atm Ataxia Telangiectasia Like Disorder Mre11 ataxia-telangiectasia-like disorder 1 Mre11 atrial fibrillation Usp3 autistic disorder Psmd14 , Rnf8 B-Cell Chronic Lymphocytic Leukemia Atm B-cell lymphoma Kat5 basal cell carcinoma Ppp6c bilateral breast cancer Atm , Brca1 bile duct cancer Atm brain cancer Atm Brain Injuries Pias1 Brain Neoplasms Atm Brain Stem Neoplasms Ppm1d branchiooculofacial syndrome Eya1 branchiootic syndrome Eya1 branchiootic syndrome 1 Eya1 branchiootorenal syndrome Eya1 branchiootorenal syndrome 1 Eya1 breast adenocarcinoma Brca1 breast cancer Atm , Brca1 , Kat5 , Kdm4a , L3mbtl1 , Nbn , Ppm1d , Rad50 , Rnf20 , Ubr5 Breast Cancer, Familial Atm , Brca1 , Nbn , Ppm1d , Rad50 breast carcinoma Atm , Brca1 , Mdc1 , Mre11 , Nbn , Rad50 breast ductal carcinoma Brca1 Breast Neoplasms Atm , Brca1 , H2ax , Ppm1d , Rad50 , Tp53bp1 Burkitt lymphoma Brca1 cancer Atm carcinoma Brca1 Cardiomegaly Kdm4a Cardiovascular Abnormalities Eya1 cataract Atm , Eya1 Cayler Cardiofacial Syndrome Eya1 cerebellar ataxia Atm cervical cancer Brca1 , Mdc1 cervix uteri carcinoma in situ Brca1 Charcot-Marie-Tooth disease type 2Y Vcp Chemical and Drug Induced Liver Injury H2ax Chromosome Breakage Brca1 , H2ax Clark-Baraitser syndrome Trip12 colon adenocarcinoma Ubr5 colon cancer Atm , Brca1 , Mre11 , Ubr5 colon carcinoma Atm , Brca1 , Nbn Colonic Neoplasms Mre11 , Tp53bp1 colorectal cancer Atm , Brca1 Colorectal Cancer 10 Atm colorectal carcinoma Brca1 Conductive Hearing Loss Eya1 Congenital Abnormalities Eya1 congenital heart disease Eya1 congenital merosin-deficient muscular dystrophy 1A Atm congenital myopathy 6 Vcp congestive heart failure Ppp2ca coronary artery disease Ppp4c COVID-19 Nbn , Rbbp8 Craniofacial Abnormalities Eya1 Cytomegalovirus Infections Vcp dementia Mre11 , Vcp depressive disorder Mre11 Desbuquois dysplasia Ppm1d , Rbbp8 Developmental Disabilities Vcp Developmental Disease Trip12 diffuse large B-cell lymphoma Nbn dilated cardiomyopathy Atm disease of cellular proliferation Atm , Brca1 disease of metabolism Nbn Disease Progression Psmd14 , Rnf168 , Vcp ductal carcinoma in situ Brca1 dysgerminoma Brca1 dystonia Mre11 eccrine porocarcinoma Mre11 Embryo Loss Ube2n endometrial cancer Atm , Mre11 endometrial carcinoma Atm , Brca1 endometrial serous adenocarcinoma Atm esophagus squamous cell carcinoma Atm , Brca1 Experimental Colitis Atm Experimental Liver Neoplasms Ppp2ca Experimental Mammary Neoplasms Brca1 , H2ax Familial Pancreatic Carcinoma Atm , Brca1 Familial Prostate Cancer Atm , Brca1 , Nbn Fanconi anemia complementation group A Brca1 Fanconi anemia complementation group S Brca1 female breast cancer Atm Fibrosis Atm focal segmental glomerulosclerosis Eya1 , Pias1 focal segmental glomerulosclerosis 1 Eya1 frontotemporal dementia Vcp frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Vcp gallbladder carcinoma Ubr5 gastric adenocarcinoma Ubr5 Gastro-Enteropancreatic Neuroendocrine Tumor Atm genetic disease Eya1 , L3mbtl1 , Ppm1d , Ppp2ca , Rbbp8 , Rnf168 , Trip12 , Vcp glioblastoma H2ax , Tp53bp1 Hearing Loss Eya1 heart disease Ppp2ca Helicobacter Infections Atm hepatoblastoma Atm hepatocellular carcinoma Atm , Nbn , Rad50 , Ubr5 hereditary breast ovarian cancer syndrome Atm , Brca1 , Mre11 , Nbn , Rad50 hereditary mixed polyposis syndrome 1 Brca1 Hereditary Neoplastic Syndromes Atm , Brca1 , Brcc3 , Mre11 , Nbn , Ppm1d , Rad50 hereditary spastic paraplegia 11 Brca1 herpes simplex virus keratitis Atm Herpesviridae Infections Atm high grade glioma Nbn , Ppm1d human immunodeficiency virus infectious disease Atm Hyperalgesia Ppp2ca Hypercholesterolemia Atm Hyperplasia Brca1 hypertension Brca1 , H2ax IgA glomerulonephritis Otub1 inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1 Vcp inclusion body myopathy with Paget disease of bone and frontotemporal dementia Vcp inclusion body myositis Vcp infant-type hemispheric glioma Brca1 infertility Atm influenza A Atm Insulin Resistance Atm INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD Ppm1d intellectual disability Trip12 , Vcp invasive ductal carcinoma Brca1 , Rad50 , Ubr5 iron deficiency anemia Kat5 Kidney Reperfusion Injury Atm , H2ax laryngeal carcinoma Ubr5 left ventricular failure Atm Left Ventricular Hypertrophy Ppp5c leukemia Atm Lewy body dementia Vcp lissencephaly Nbn liver benign neoplasm H2ax liver cancer Atm liver cirrhosis Atm , Rad50 Liver Reperfusion Injury H2ax long QT syndrome Ubr5 lung adenocarcinoma Mre11 , Ubr5 Lung Agenesis Eya1 lung cancer Atm , Brca1 , Kdm4a lung carcinoma Mdc1 , Ppm1d lung non-small cell carcinoma Atm , Brca1 , Rnf168 , Tp53bp1 , Ubr5 lung sarcomatoid carcinoma Rad50 lung small cell carcinoma Atm lung squamous cell carcinoma Atm lupus nephritis Otub1 Lymphatic Metastasis Tp53bp1 lymphoma Atm lymphopenia Usp3 Lynch syndrome Mre11 Lynch syndrome 1 Atm malignant astrocytoma Mre11 malignant mesothelioma Kat5 mantle cell lymphoma Atm melanoma Atm , Kdm4a , Ppp6c Metabolic Syndrome Atm microcephaly Atm , Nbn , Rbbp8 Microcephaly with Mental Retardation and Digital Anomalies Rbbp8 Micronuclei, Chromosome-Defective H2ax mitochondrial myopathy Eya1 mouth disease Brca1 multiple myeloma Atm , Rbbp8 Muscle Weakness Vcp myocardial infarction Atm , Rad50 Myocardial Ischemia Ppp2ca Myocardial Reperfusion Injury H2ax myoepithelioma Rad50 nasopharynx carcinoma Atm , Brca1 nemaline myopathy 2 Rif1 Neoplasm Recurrence, Local H2ax , Nbn Neoplastic Cell Transformation Brca1 nephrogenic diabetes insipidus Rnf40 nephronophthisis Pias1 neuroblastoma Psmd14 Neurocutaneous Syndromes Mre11 Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities Ppp2ca NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES Kat5 Neurodevelopmental Disorders Ppm1d , Trip12 , Ubr5 neutropenia Usp3 Nijmegen breakage syndrome Nbn Nijmegen Breakage Syndrome-Like Disorder Rad50 Occupational Diseases Brcc3 oligoasthenoteratozoospermia Ppp4c oral mucosa leukoplakia Atm , H2ax oral squamous cell carcinoma Atm , H2ax osteoporosis Atm Otofaciocervical Syndrome 1 Eya1 Otorhinolaryngologic Neoplasms Atm ovarian cancer Atm , Brca1 , Mre11 , Nbn , Ppm1d , Rad50 ovarian carcinoma Atm , Brca1 , Nbn Ovarian Neoplasms Atm , Brca1 , Mre11 , Tp53bp1 ovary serous adenocarcinoma Brca1 Paget's disease of bone Vcp pancreatic cancer Atm , Brca1 , Tp53bp1 pancreatic carcinoma Brca1 , Nbn , Rbbp8 papillary thyroid carcinoma Atm paraplegia Vcp Parkinson's disease Atm , Ppp2ca Parkinsonism Mre11 peripheral T-cell lymphoma Atm peritoneum cancer Brca1 periventricular nodular heterotopia Brca1 Pneumococcal Meningitis Atm polycythemia vera Atm Polyploidy H2ax pre-malignant neoplasm Atm , Ppm1d Pregnancy in Diabetics Brcc3 Premature Aging Brca1 premature menopause Rad50 Prenatal Exposure Delayed Effects Atm primary cutaneous T-cell non-Hodgkin lymphoma Atm primary ovarian insufficiency Mre11 , Nbn , Rad50 prostate cancer Atm , Brca1 , Eya1 , Kdm4a , Nbn , Ppp2ca , Rad50 , Trip12 prostate carcinoma in situ Atm Prostatic Neoplasms Atm , Brca1 , Kat5 , Mre11 , Nbn , Vcp pulmonary hypertension Tp53bp1 punctate palmoplantar keratoderma type II Brca1 Radiation Pneumonitis Atm rectum cancer Mre11 , Nbn renal agenesis Eya1 renal hypoplasia Eya1 Retroviridae Infections Atm rhabdomyosarcoma Brca1 Rhabdoviridae Infections Atm Riddle syndrome Rnf168 Seckel syndrome Rbbp8 Seckel syndrome 2 Rbbp8 senile cataract Atm Sepsis Atm skin disease Pias1 Spinal Cord Injuries Atm spondylocostal dysostosis 5 Ppp4c squamous cell carcinoma Atm , Rnf168 status epilepticus Atm , H2ax Stevens-Johnson syndrome Vcp stomach cancer Atm , Brca1 , Nbn , Ubr5 stomach carcinoma Brca1 , Kdm4a , Mdc1 , Mre11 Stomach Neoplasms Atm stomatitis Nbn Streptococcus pneumonia Atm T-cell acute lymphoblastic leukemia Nbn T-cell prolymphocytic leukemia Atm Testicular Neoplasms Rnf4 transient cerebral ischemia H2ax transitional cell carcinoma Rad50 Triple Negative Breast Neoplasms Brca1 , Mre11 type 2 diabetes mellitus Ppp2ca urinary bladder cancer Atm , Brca1 , Kdm4a , Mre11 Urinary Bladder Neoplasm Brca1 uterine corpus cancer Brca1 Williams-Beuren syndrome Baz1b X-linked cardiac valvular dysplasia Atm